Multiple Sclerosis Amongst Chinese in Hong Kong

Yu, Y. L.; Woo, Eunge; Hawkins, B. R.; Ho, Hui-Chen; Huang, Chi‐Chang

doi:10.1093/brain/112.6.1445

Cited by 71 publications

(39 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…MS mortality was higher in whites than in other racial/ethnic groups, followed by Blacks, Hispanics, American Indians/Alaska Natives and Asians/Pacifi c Islanders. Previous studies have suggested that the prevalence of MS may be considerably lower in Hong Kong, Japan, Taiwan and India than it is in the US [31][32][33][34] . The MS mortality rate in Asians/Pacifi c Islanders was less than one tenth of the observed mortality rate in whites.…”

Section: Discussionmentioning

confidence: 99%

Multiple Sclerosis Mortality and Patterns of Comorbidity in the United States from 1990 to 2001

Redelings¹,

McCoy²,

Sorvillo³

2006

Neuroepidemiology

View full text Add to dashboard Cite

Multiple sclerosis (MS) is a neurodegenerative condition that can result in cognitive and physical disability and shortened life expectancy. However, population-based information is lacking regarding the mortality burden from MS in the United States. We investigated trends in MS mortality rates and examined important comorbidities in the United States from 1990 to 2001. MS deaths were matched by age, sex, and race/ethnicity with randomly selected deaths from other conditions for matched odds ratio comparisons. The overall age-adjusted mortality rate from MS was 1.44/100,000 population. MS mortality rates increased throughout the study period. MS mortality rates were higher in whites than in any other racial/ethnic group, followed by Blacks, Hispanics, American Indians/Alaska Natives, and Asians and Pacific Islanders. Observed mortality rates were more than 10 times lower in Asians and Pacific Islanders than in whites. The odds of pressure ulcers, urinary tract infections, and pneumonia/influenza being reported on the death certificate were higher in MS deaths than in matched controls.

show abstract

Section: Discussionmentioning

confidence: 99%

Multiple Sclerosis Mortality and Patterns of Comorbidity in the United States from 1990 to 2001

Redelings¹,

McCoy²,

Sorvillo³

2006

Neuroepidemiology

View full text Add to dashboard Cite

show abstract

“…The prevalence of MS in Taiwan is lower than that of most Asian countries except China Shanghai [25] . An increase in prevalence with time is not only observed in Taiwan, but also in other Asian countries, including Japan, Hong Kong, Kuwait and Jordan [17,18,[26][27][28][29][30][31][32][33][34] . The ascertainment of MS has been greatly improved with the utility of magnetic resonance imaging, which has become more and more widely available in the recent 2 decades.…”

Section: Creutzfeldt-jakob Diseasementioning

confidence: 99%

Population-Based Epidemiological Study of Neurological Diseases in Taiwan: I. Creutzfeldt-Jakob Disease and Multiple Sclerosis

Lai

Tseng

2009

Neuroepidemiology

View full text Add to dashboard Cite

Background: The purpose of the study is to investigate the epidemiology of Creutzfeldt-Jakob disease (CJD) and multiple sclerosis (MS) in Taiwan. Methods: Cases of CJD and MS were identified from the National Health Insurance Research Database from January 2000 to December 2005. Age- and sex-specific incidences of these diseases were estimated by dividing the incidence number by population data obtained from the Department of Statistics, Ministry of the Interior. Results: During the study period, 79 cases of CJD, 41 women and 38 men, were identified. The average annual incidence rate was 0.63/million. Most cases were older than 60 years. There were 1,262 cases of MS. The male-to-female ratio was 0.4. The average annual incidence rate was 0.79/100,000. The incidence reached a peak at the age group of 40–60 years for females and at the age group of over 55 years for males. The prevalence of MS was 2.96/100,000 in 2005, which is higher than those of previous studies in Taiwan. Conclusions: The annual incidence rate of CJD in Taiwan is lower than in western countries. The annual incidence rate and prevalence of MS in Taiwan are low. The prevalence of MS in Taiwan increased in recent decades.

show abstract

“…Damit gehört Deutschland mit den skandinavischen Ländern, Schottland, Island, den USA, Kanada und Australien zu den Hochrisikogebieten weltweit (Prävalenzraten > 30/100.000) (Compston 1997). Die Prävalenz unter Schwarzafrikanern und Asiaten ist mit 5/100.000 dagegen gering (Kuroiwa Y 1982;Yu YL 1989;Miller DH 1990;Poser CM 1994). Einwanderer aus asiatischen Ländern in die USA oder nach Europa haben ein höheres Risiko zu erkranken als in ihrem Ursprungsland.…”

Section: Epidemiologie Der Msunclassified